Patient portrayal of a woman sitting at a kitchen counter looking at a laptop computer
Patient portrayal of a woman sitting at a kitchen counter looking at a laptop computer

Assistance at every step

No matter where you are on your QfitliaTM (fitusiran) journey—newly diagnosed, changing treatments, or helping to care for a loved one—you’ve come to the right place.

Qfitlia logo

HemAssist for Qfitlia

Once you’ve been prescribed Qfitlia, you can enroll in HemAssist to get the support you need to start and stay with treatment. We provide financial assistance options, help you navigate insurance, and provide supplemental training on how to inject. Get started by enrolling now.

After you enroll, your HemAssist team will call you within 24 hours to welcome you to the program and explain what to expect. Save 1-833-723-5463 to your contacts.

Qfitlia logo

OUR SUPPORT

Decorative wallet icon

Affording Qfitlia

No matter your situation, we are committed to helping you access and afford treatment. Your team will verify your insurance coverage and determine what financial assistance programs you may be eligible for.

Decorative 1-2-3 steps icon

Starting treatment

Your team can help you get started with Qfitlia right away. We'll provide supplemental training on how to inject, answer questions about antithrombin (AT) testing, and support your bleed management plan.

Decorative conversation bubble icon

Ongoing support

Our team provides support and education throughout your Qfitlia journey. This includes helping you understand dosing changes from your doctor, navigating new insurance, and more.

Financial assistance

Patient portrayal of a smiling man sitting at a desk speaking on a mobile phone

Our team can help determine if you may be eligible for financial assistance.

Patient portrayal of a smiling man sitting at a desk speaking on a mobile phone

SELECT YOUR INSURANCE TYPE

Click the option that best applies to you.

If you have commercial insurance (insurance sponsored by your employer or private insurance) and you’re having trouble paying for Qfitlia, HemAssist's Copay Assistance Program* may be able to help. Get Qfitlia for as little as $0 with annual maximum savings up to $20,000 with no income caps. Check eligibility.


Additionally, patients prescribed Qfitlia for the first time can receive up to 6 months of product while their insurance coverage is pending through the QuickStart program.

If you have government insurance, including Medicare, Medicaid, or insurance obtained through the Healthcare Marketplace, HemAssist’s Patient Assistance Program may be available to help with Qfitlia out-of-pocket costs for eligible patients. Call 1-833-7263 to check your eligibility.

If you experience a loss of coverage or are facing other insurance barriers, the Bridge Program may be able to help with access to Qfitlia. Call 1-833-7263 to learn more.

If you’re unsure about what kind of insurance you have or if you have insurance at all, call our HemAssist Case Management team at 1-833-723-5463. Someone can assist you Monday – Friday 8 AM to 7 PM ET.

*Not valid if the patient is utilizing a state or federally funded health insurance program such as Medicare (including Medicare Part D), Medicaid, Medigap, VA, DoD, TRICARE®, state pharmaceutical assistance program, etc. to pay in part or in full for their QFITLIA prescription. Not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Copay Program at any time without notice. Savings by patients may vary depending on their out-of-pocket costs. The program is intended to help patients afford their QFITLIA prescription. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms.


Claims for free products dispensed through the QuickStart, Patient Assistance or Bridge Programs shall not be submitted to any third-party payer, public or private (e.g. private insurance, Medicaid, Medicare, VA, DoD, TRICARE®, or similar federal or state programs) for reimbursement. All Programs not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Programs at any time without notice. Program details provided upon registration.

hemassist logo
Need help paying for Qfitlia?
Talk to a Case Manager to find out which programs you may be eligible for. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Enroll now

Getting started

Patient portrayal of a man and woman  sitting on a sofa looking at a laptop computer

Starting a new treatment may come with a lot to learn. That’s why you have a dedicated HemAssist team with support on your side. From digital resources to personalized check-ins, HemAssist is here to help you get started with confidence.

Your Case Manager and TEM will welcome you to the program within 24 hours after you enroll. Then they’ll follow up with resources to help you get started with supplemental injection training, antithrombin (AT) testing, the dosing adjustment process, and more.

Patient portrayal of a man and woman  sitting on a sofa looking at a laptop computer

RESOURCES FOR STARTING QFITLIA

Starter guide icon

Qfitlia starter guide

At home testing injection video tutorial icon

Injection training videos

Bleed management  video tutorial icon

Bleed management guide

Support along the way

Portrayal of a smiling woman in an office wearing a headset

Support starts with HemAssist and is with you throughout your treatment. Your team is ready to assist you at any point in your Qfitlia journey.

Portrayal of a smiling woman in an office wearing a headset

MEET YOUR TEAM

Therapeutic Education Manager (TEM)

Provides guidance throughout your Qfitlia journey. Answers questions about injecting, antithrombin (AT) testing, dosing changes prescribed by your doctor, building an
injection routine, and more.

Case Manager

Assists with navigating insurance coverage and identifying available financial support that you may be eligible for.

Community Relations and Education Manager (CoRe)

Educates and empowers those within the hemophilia community through one-to-one communication, community events, and conferences.

REASONS TO REACH OUT

Your TEM and Case Manager are available to assist you at any point along your Qfitlia journey.

Your doctor may adjust your dose if your antithrombin (AT) levels are outside the normal range. Your TEM can help you understand your dosing and what it means for you. Call 1-833-723-5463 Monday - Friday 8 AM to 7 PM ET.

Your TEM can provide supplemental injection training support along with helpful tips about building a treatment routine. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

What is antithrombin and what does it mean for you? Your TEM can help you understand Qfitlia and how it works. They can also help remind you when it’s time to get your antithrombin test. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

When you change or start new insurance, you may have questions about affording Qfitlia. Contact your Case Manager for help navigating the process. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

These are important milestones not only in adulthood, but also in treatment responsibility. Your team can help you navigate life changes such as going to college, starting a new job, or choosing insurance for the first time. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

Starting and staying with a new treatment takes dedication. Your TEM can help with tips for injection day, building your treatment routine, and help maintaining motivation when you need it. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

Resources from the community

National bleeding disorders foundation logo

National Bleeding Disorders Foundation

Hemophilia federation of America logo

Hemophilia Federation of America

World Federation of Hemophilia logo

World Federation 
of Hemophilia

National organization for rare disorders logo

National Organization for Rare Disorders

This listing is provided as a resource only and does not constitute an endorsement by Sanofi of any particular organiation or its programming. Additional resources on this topic may be available and should be investigated. Sanofi does not review or control the content of non-Sanofi websites.

Large HemAssist logo
Need to enroll?
If you’ve been prescribed Qfitlia but haven’t yet enrolled in HemAssist, support is only a few steps away. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET for help enrolling.
Enroll now

Important Safety Information and Indication
INDICATION
IMPORTANT SAFETY INFORMATION
INDICATION
Qfitlia™ (fitusiran) is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years and older with hemophilia A or B, with or without Factor VIII or IX inhibitors.

It is not known if Qfitlia is safe and effective in children younger than 12 years of age.
IMPORTANT SAFETY INFORMATION

Qfitlia can cause SERIOUS SIDE EFFECTS, including:

  • Abnormal blood clotting (thrombotic events): Serious blood clots have occurred in people treated with Qfitlia. Qfitlia can cause blood clots to form in the blood vessels in your arms, legs, lungs, heart, brain, eyes, or head. Your risk of blood clots is greater if your antithrombin (AT) blood level is persistently less than 15% or if you have certain other conditions. Your healthcare provider (HCP) will check your AT blood levels before and during treatment with Qfitlia.

  • Gallbladder disease: Qfitlia can cause gallstones and inflammation of your gallbladder, which might require surgery to remove your gallbladder. Tell your HCP right away if you develop stomach pain, indigestion, nausea, or vomiting. Your HCP may temporarily or permanently stop Qfitlia if you develop any of these symptoms.


What is the most important information I should know about Qfitlia?

Qfitlia helps your blood form clots. Do not stop using Qfitlia without talking to your HCP. If you miss doses or stop using Qfitlia, you may no longer be protected against bleeding.


Use of a clotting factor concentrate (CFC) or bypassing agent (BPA) to help protect against bleeding must be stopped within 7 days after your first dose of Qfitlia.


Your HCP may prescribe on-demand CFC or BPA if you bleed during treatment with Qfitlia. Carefully follow your HCP’s instructions regarding when to use on-demand treatment with CFC or BPA, including the prescribed dose and timing of the CFC or BPA.


Get medical help right away if you get any of these signs or symptoms of blood clots during or after treatment with Qfitlia:

  • Swelling, pain, or redness in arms or legs
  • Coughing up blood
  • Shortness of breath
  • Severe chest pain or tightness of the chest
  • Fast heart rate
  • Feeling faint or passing out
  • Severe or persistent headache
  • Difficulty speaking or understanding language
  • Feeling confused
  • Numbness or weakness in your face, arms, or legs
  • Sudden loss or changes in your vision, eye pain, or swelling

What are the possible side effects of Qfitlia?

  • Qfitlia can cause other serious side effects, including an increase in your blood liver enzymes. Your HCP will do blood tests to check your liver function before and during treatment with Qfitlia.

  • The most common side effects of Qfitlia include viral infection, common cold symptoms, and bacterial infection

  • These are not all the possible side effects of Qfitlia.


What should I tell my HCP before using Qfitlia?

  • Tell your HCP about all of your medical conditions, including if you have liver problems, a history of gallbladder disease, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.

  • Females who are able to become pregnant: Hormonal birth control may increase your risk of blood clots if used during treatment with Qfitlia. Talk to your HCP about effective forms of non-hormonal birth control you can use before starting and during treatment with Qfitlia.

  • Tell your HCP about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

© 2025 Sanofi. All rights reserved. Qfitlia, HemAssist, and Sanofi are trademarks of Sanofi or an affiliate. All other trademarks are the property of their respective owners. All other trademarks are the property of their respective owners. MAT-US-2412764-v1.0-03/2025